# DND1

## Overview
DND1, or dead end 1, is a gene that encodes the DND microRNA-mediated repression inhibitor 1 protein, a crucial RNA-binding protein involved in post-transcriptional gene regulation. This protein is characterized by its tandem RNA recognition motifs (RRMs), which facilitate its primary function of binding to uridine-rich regions in the 3' untranslated regions of mRNAs. By doing so, DND1 inhibits microRNA (miRNA) access, thereby preventing miRNA-mediated repression of target mRNAs. This regulatory mechanism is vital for maintaining gene expression, particularly in germline cells, where DND1 plays a significant role in preserving pluripotency and preventing somatic differentiation. The protein's activity is predominantly cytoplasmic, where it influences cell differentiation and proliferation. DND1's interactions extend to various proteins and complexes, such as the CCR4-NOT deadenylase complex, further highlighting its multifaceted role in gene expression regulation. Mutations and altered expression of the DND1 gene have been linked to several diseases, including cancers and infertility, underscoring its clinical significance (Mall2021Heading; Zhang2021The; Kedde2007RNA-Binding).

## Structure
The DND1 protein is characterized by its unique molecular structure, which includes tandem RNA recognition motifs (RRMs) crucial for its function in RNA binding. The primary structure of DND1 includes two RRMs, RRM1 and RRM2, connected by a short interdomain linker, which is atypical among RNA-binding proteins (Duszczyk2022The). RRM1 serves as the main RNA-binding platform and features a noncanonical fold with a conserved N-terminal extension forming a β-hairpin packed against an α-helix, creating an extended surface known as the eRRM fold (Duszczyk2022The). RRM2, on the other hand, has a C-terminal helical extension and an atypical binding pocket that enhances RNA-binding affinity and specificity (Duszczyk2022The).

The tertiary structure of DND1 reveals a complex mode of RNA recognition, where the RNA is sandwiched between the two RRMs, with RRM2 stabilizing the interaction through an unusual binding pocket (Duszczyk2022The). The quaternary structure is not explicitly detailed, but the tandem RRMs work cooperatively to bind AU-rich RNA sequences with high affinity, which is essential for DND1's role in post-transcriptional gene regulation (Duszczyk2022The). The dsRBD domain, although not necessary for binding all targets, may contribute to the specificity of DND1 by recognizing stem-loop motifs adjacent to linear motifs recognized by the RRMs (Duszczyk2022The).

## Function
The DND1 protein, also known as DND microRNA-mediated repression inhibitor 1, plays a critical role in regulating gene expression by inhibiting microRNA (miRNA) access to target mRNAs. This function is essential in maintaining the expression of specific genes in healthy human cells, particularly in germline cells. DND1 achieves this by binding to uridine-rich regions (URRs) in the 3' untranslated regions (3' UTRs) of mRNAs, which reduces the affinity of these mRNAs to miRNAs, thereby preventing miRNA-mediated gene suppression (Kedde2007RNA-Binding). 

In human cells, DND1 has been shown to inhibit the interaction of miR-221 with its target p27 mRNA, leading to increased p27 expression levels. This indicates that DND1 modulates miRNA accessibility to ensure proper gene expression (Kedde2007RNA-Binding). DND1's activity is crucial for the survival and fate maintenance of primordial germ cells (PGCs) and the development of the male germline, as it helps maintain germ cell fate by inhibiting somatic differentiation and preserving pluripotency (Mall2021Heading). 

DND1 is primarily active in the cytoplasm, where it influences cell differentiation and proliferation by modulating gene expression through its interactions with mRNA (Zhu2011Transcripts).

## Clinical Significance
Mutations and altered expression of the DND1 gene have been implicated in various diseases, particularly cancers and infertility. In germ cell development, mutations such as the Ter mutation in mice lead to a high incidence of testicular germ cell tumors (TGCTs) and infertility due to the loss of primordial germ cells (Zhang2021The; Ruthig2019The). In humans, DND1 variants have been linked to male infertility, specifically non-obstructive azoospermia, as demonstrated by a homozygous missense variant (c.212A>C, p.E71A) found in a Pakistani family (Xie2022A). 

In cancer, DND1 expression levels vary across different types. In breast cancer, higher DND1 levels correlate with longer overall survival, while lower levels are associated with more metastatic cell lines (Zhang2021The). In colorectal cancer, DND1 is up-regulated, promoting cell proliferation, whereas in tongue squamous cell carcinoma, reduced expression enhances proliferation and reduces apoptosis (Zhang2021The). DND1 also plays a role in acute myeloid leukemia, where lower levels affect cell differentiation (Zhang2021The). The gene's function can be context-dependent, acting as a tumor suppressor or potentially oncogenic, influenced by the cellular environment and its interactions with mRNA and proteins (Zhang2021The).

## Interactions
DND1 (DND microRNA-mediated repression inhibitor 1) is an RNA-binding protein that interacts with various nucleic acids and proteins to regulate gene expression. It binds to the 3'-untranslated regions (3'-UTRs) of specific mRNAs, blocking microRNA (miRNA) access and preventing miRNA-mediated mRNA degradation. This interaction is facilitated by uridine-rich regions (URRs) on the mRNA, allowing DND1 to up-regulate translation of target mRNAs such as p27 and geminin by blocking miRNAs like miR-221 and miR-372 (Zhang2021The; Kedde2007RNA-Binding).

DND1 also interacts with the CCR4-NOT deadenylase complex, which is involved in mRNA degradation. This interaction allows DND1 to destabilize certain mRNAs, including those related to apoptosis and inflammation (Zhang2021The; Ruthig2019The). In germ cells, DND1 partners with NANOS2, facilitating the loading of specific RNAs into the Nanos2-CCR4-NOT complex (Zhang2021The).

DND1's RNA recognition motifs (RRMs) are crucial for its interaction with mRNA targets. RRM1 is essential for mRNA binding, while RRM2 has ATP-dependent helicase activity to resolve mRNA secondary structures (Zhang2021The). DND1 also interacts with proteins such as APOBEC3, which can counteract DND1's function by restoring miRNA suppressive activity (Zhang2021The).


## References


[1. (Xie2022A) Xuefeng Xie, Mazhar Khan, Muhammad Zubair, Abbas Khan, Ranjha Khan, Jianteng Zhou, Yuanwei Zhang, Muzafar Said, Sher Ali Khan, Qamar Zaman, Ghulam Murtaza, Muzamil Ahmad Khan, Wei Liu, Xiaoning Hou, Huan Zhang, Bo Xu, Xiaohua Jiang, Shun Bai, and Qinghua Shi. A homozygous missense variant in dnd1 causes non-obstructive azoospermia in humans. Frontiers in Genetics, September 2022. URL: http://dx.doi.org/10.3389/fgene.2022.1017302, doi:10.3389/fgene.2022.1017302. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fgene.2022.1017302)

[2. (Ruthig2019The) Victor A. Ruthig, Matthew B. Friedersdorf, Jason A. Garness, Steve C. Munger, Corey Bunce, Jack D. Keene, and Blanche Capel. The rna-binding protein dnd1 acts sequentially as a negative regulator of pluripotency and a positive regulator of epigenetic modifiers required for germ cell reprogramming. Development, July 2019. URL: http://dx.doi.org/10.1242/dev.175950, doi:10.1242/dev.175950. This article has 20 citations and is from a peer-reviewed journal.](https://doi.org/10.1242/dev.175950)

[3. (Duszczyk2022The) Malgorzata M. Duszczyk, Harry Wischnewski, Tamara Kazeeva, Rajika Arora, Fionna E. Loughlin, Christine von Schroetter, Ugo Pradère, Jonathan Hall, Constance Ciaudo, and Frédéric H.-T. Allain. The solution structure of dead end bound to au-rich rna reveals an unusual mode of tandem rrm-rna recognition required for mrna regulation. Nature Communications, October 2022. URL: http://dx.doi.org/10.1038/s41467-022-33552-x, doi:10.1038/s41467-022-33552-x. This article has 5 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-022-33552-x)

[4. (Mall2021Heading) Eva M. Mall, Aaron Lecanda, Hannes C. A. Drexler, Erez Raz, Hans R. Schöler, and Stefan Schlatt. Heading towards a dead end: the role of dnd1 in germ line differentiation of human ipscs. PLOS ONE, 16(10):e0258427, October 2021. URL: http://dx.doi.org/10.1371/journal.pone.0258427, doi:10.1371/journal.pone.0258427. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0258427)

[5. (Kedde2007RNA-Binding) Martijn Kedde, Markus J. Strasser, Bijan Boldajipour, Joachim A.F. Oude Vrielink, Krasimir Slanchev, Carlos le Sage, Remco Nagel, P. Mathijs Voorhoeve, Josyanne van Duijse, Ulf Andersson Ørom, Anders H. Lund, Anastassis Perrakis, Erez Raz, and Reuven Agami. Rna-binding protein dnd1 inhibits microrna access to target mrna. Cell, 131(7):1273–1286, December 2007. URL: http://dx.doi.org/10.1016/j.cell.2007.11.034, doi:10.1016/j.cell.2007.11.034. This article has 578 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.cell.2007.11.034)

[6. (Zhang2021The) Yun Zhang, Jyotsna D. Godavarthi, Abie Williams-Villalobo, Shahrazad Polk, and Angabin Matin. The role of dnd1 in cancers. Cancers, 13(15):3679, July 2021. URL: http://dx.doi.org/10.3390/cancers13153679, doi:10.3390/cancers13153679. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/cancers13153679)

[7. (Zhu2011Transcripts) Rui Zhu, Michelina Iacovino, Elisabeth Mahen, Michael Kyba, and Angabin Matin. Transcripts that associate with the rna binding protein, dead-end (dnd1), in embryonic stem (es) cells. BMC Molecular Biology, August 2011. URL: http://dx.doi.org/10.1186/1471-2199-12-37, doi:10.1186/1471-2199-12-37. This article has 29 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/1471-2199-12-37)